We are live on ! Find out more
DMPV

Delphi Management Partners VIII Portfolio holdings

AUM $138M
1-Year Est. Return 56.74%
This Fund
S&P 500
This Quarter Est. Return
+43.31%
1 Year Est. Return
+56.74%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
–
Cap. Flow
+$114M
Cap. Flow %
89.88%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$61.7M
2
KPTI icon
Karyopharm Therapeutics
KPTI
+$32.7M
3
SENS icon
Senseonics Holdings Inc
SENS
+$9.71M
4
CALA
Calithera Biosciences, Inc
CALA
+$9.13M
5
MREO
Mereo BioPharma
MREO
+$656K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 89.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNDM icon
1
Tandem Diabetes Care
TNDM
$1.17B
$59.6M 47.05%
+1,000,000
New +$61.7M
KPTI icon
2
Karyopharm Therapeutics
KPTI
$216M
$43.4M 34.24%
+150,867
New +$32.7M
CALA
3
DELISTED
Calithera Biosciences, Inc
CALA
$13.9M 10.94%
+121,335
New +$9.13M
SENS icon
4
Senseonics Holdings Inc
SENS
$267M
$9.02M 7.12%
+492,315
New +$9.71M
MREO
5
Mereo BioPharma
MREO
$49.5M
$842K 0.66%
+256,734
New +$656K

Similar funds

HC
Hatton Consulting Phoenix, Arizona $134M AUM
FIG
Freed Investment Group Boston, Massachusetts $131M AUM 30.59% 1-Year Est. Return
BRC
BHF RG Capital Scottsdale, Arizona $150M AUM 18.4% 1-Year Est. Return
RP
RBS Partners Bay Harbor Islands, Florida $155M AUM 153.45% 1-Year Est. Return
CSM
CAMG Solamere Management Charlotte, North Carolina $122M AUM 33.76% 1-Year Est. Return
SVC
Strycker View Capital New York $156M AUM 73.52% 1-Year Est. Return
SCM
Symons Capital Management Pittsburgh, Pennsylvania $156M AUM 9.32% 1-Year Est. Return
KGA
KPCB GGF Associates Menlo Park, California $157M AUM

Delphi Management Partners VIII's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Delphi Management Partners VIII, which disclosed 5 positions worth $127M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Tandem Diabetes Care: 1,000,000 shares worth $59.6M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets.

  • Delphi Management Partners VIII's largest Q4 2019 buy was Tandem Diabetes Care: 1,000,000 shares worth $59.6M.
  • Delphi Management Partners VIII's ten largest holdings make up 100% of its $127M portfolio in Q4 2019.
  • Delphi Management Partners VIII disclosed 5 positions in Q4 2019, its first 13F filing on record.

Based on Delphi Management Partners VIII's 13F filing for Q4 2019, filed 7 Feb 2020.